Compare TREE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TREE | VNDA |
|---|---|---|
| Founded | 1996 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.5M | 361.4M |
| IPO Year | 2008 | 2005 |
| Metric | TREE | VNDA |
|---|---|---|
| Price | $25.91 | $5.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $71.25 | $14.90 |
| AVG Volume (30 Days) | 387.4K | ★ 635.3K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 443.31 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $1,117,324,000.00 | $216,105,000.00 |
| Revenue This Year | $19.03 | $21.35 |
| Revenue Next Year | $7.07 | $37.40 |
| P/E Ratio | $13.69 | ★ N/A |
| Revenue Growth | ★ 24.12 | 8.72 |
| 52 Week Low | $25.98 | $4.27 |
| 52 Week High | $74.53 | $9.91 |
| Indicator | TREE | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 30.37 | 42.97 |
| Support Level | N/A | $4.94 |
| Resistance Level | $39.74 | $5.55 |
| Average True Range (ATR) | 1.03 | 0.18 |
| MACD | 0.15 | -0.03 |
| Stochastic Oscillator | 9.56 | 17.14 |
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.